Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.33 Billion INR | -27.68% |
| 2022 | 1.85 Billion INR | 15.31% |
| 2021 | 1.6 Billion INR | 5.42% |
| 2020 | 1.52 Billion INR | 30.36% |
| 2019 | 1.16 Billion INR | 3.08% |
| 2018 | 1.13 Billion INR | 161.85% |
| 2017 | 432.84 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 316.88 Million INR | -16.05% |
| 2023 Q2 | 567.97 Million INR | 6.59% |
| 2023 Q3 | 605.7 Million INR | 6.64% |
| 2023 FY | 1.33 Billion INR | -27.68% |
| 2023 Q1 | 532.83 Million INR | 8.0% |
| 2023 Q4 | 377.46 Million INR | -37.68% |
| 2022 Q2 | 483.21 Million INR | 11.09% |
| 2022 FY | 1.85 Billion INR | 15.31% |
| 2022 Q4 | 493.36 Million INR | 12.18% |
| 2022 Q3 | 439.79 Million INR | -8.99% |
| 2022 Q1 | 434.98 Million INR | 8.45% |
| 2021 Q4 | 401.07 Million INR | -1.27% |
| 2021 FY | 1.6 Billion INR | 5.42% |
| 2021 Q3 | 406.24 Million INR | 1.1% |
| 2021 Q2 | 401.82 Million INR | 1.36% |
| 2021 Q1 | 396.44 Million INR | 13.7% |
| 2020 Q4 | 348.66 Million INR | -20.91% |
| 2020 Q3 | 440.84 Million INR | 18.67% |
| 2020 Q1 | 362.1 Million INR | 43.47% |
| 2020 Q2 | 371.48 Million INR | 2.59% |
| 2020 FY | 1.52 Billion INR | 30.36% |
| 2019 FY | 1.16 Billion INR | 3.08% |
| 2019 Q4 | 252.38 Million INR | 0.0% |
| 2018 FY | 1.13 Billion INR | 161.85% |
| 2017 FY | 432.84 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 95.001% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 99.134% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 89.232% |
| Granules India Limited | 16.79 Billion INR | 92.031% |
| Indoco Remedies Limited | 6.04 Billion INR | 77.839% |
| Achyut Healthcare Limited | 4.86 Million INR | -27441.658% |
| Ajanta Pharma Limited | 21.06 Billion INR | 93.644% |
| Alkem Laboratories Limited | 52.29 Billion INR | 97.44% |
| Alpa Laboratories Limited | 188.89 Million INR | -608.754% |
| Brooks Laboratories Limited | 65.62 Million INR | -1940.232% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 78.485% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 9.037% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 63.772% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.182% |
| Eris Lifesciences Limited | 10.42 Billion INR | 87.16% |
| FDC Limited | 8.33 Billion INR | 83.937% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 98.069% |
| Gufic Biosciences Limited | 4.16 Billion INR | 67.877% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 78.387% |
| Ipca Laboratories Limited | 29.8 Billion INR | 95.509% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -105.152% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -594.661% |
| Lasa Supergenerics Limited | 121.02 Million INR | -1006.172% |
| Laurus Labs Limited | 24.62 Billion INR | 94.562% |
| Lupin Limited | 123.71 Billion INR | 98.918% |
| Mankind Pharma Limited | 44.52 Billion INR | 96.993% |
| Medicamen Biotech Limited | 495.49 Million INR | -170.194% |
| Medico Remedies Limited | 262.14 Million INR | -410.712% |
| Megasoft Limited | 342.07 Million INR | -291.381% |
| NATCO Pharma Limited | 25.73 Billion INR | 94.798% |
| Piramal Pharma Limited | 24.47 Billion INR | 94.529% |
| RPG Life Sciences Limited | 2.48 Billion INR | 46.081% |
| Sigachi Industries Limited | 2 Billion INR | 33.136% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.482% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 67.531% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -42.063% |
| Unichem Laboratories Limited | 4.86 Billion INR | 72.481% |
| Wanbury Limited | 1.73 Billion INR | 22.641% |
| ZIM Laboratories Limited | 1.26 Billion INR | -5.676% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.931% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 322.242% |
| Divi's Laboratories Limited | 32.44 Billion INR | 95.873% |
| Hester Biosciences Limited | 1.27 Billion INR | -5.115% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 76.843% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | 13.988% |
| Bal Pharma Limited | 770.19 Million INR | -73.826% |
| Strides Pharma Science Limited | 14.38 Billion INR | 90.695% |
| Venus Remedies Limited | 2.18 Billion INR | 38.66% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 77.041% |
| Nectar Lifesciences Limited | 2.97 Billion INR | 54.954% |
| Shilpa Medicare Limited | 3.54 Billion INR | 62.254% |
| Aarti Drugs Limited | 8.31 Billion INR | 83.901% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 70.774% |
| Suven Life Sciences Limited | -200.79 Million INR | 766.743% |
| Ind-Swift Limited | 2.17 Billion INR | 38.376% |
| Valiant Laboratories Limited | -60.66 Million INR | 2306.91% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 94.102% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -55.458% |
| Themis Medicare Limited | 1.5 Billion INR | 10.978% |
| Hikal Limited | 3.14 Billion INR | 57.405% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 97.137% |
| Sequent Scientific Limited | 2.97 Billion INR | 55.055% |
| Novartis India Limited | 1.32 Billion INR | -0.897% |
| Wockhardt Limited | 16.24 Billion INR | 91.756% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 93.184% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -9082.631% |
| Neuland Laboratories Limited | 8.24 Billion INR | 83.768% |
| Morepen Laboratories Limited | 6.16 Billion INR | 78.271% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -115.769% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -90.277% |